Press Releases Indicate Itamar Medical For Investors Is a Good Option

Adam Goldbloom
Created by Adam Goldbloom (User Generated Content*)User Generated Content is not posted by anyone affiliated with, or on behalf of, Playbuzz.com.
On Jan 22, 2019
Help Translate This Item

Press Releases Indicate Itamar Medical For Investors Is a Good Option


Itamar medical press releases indicate the company has achieved an increase of 14.7% in third-quarter revenue to record $6.1 million. Their revenues increased by 29% in the US compared with the third quarter of 2017. The gross profit of the company remained strong at 74.3% of total revenues. These figures should make Itamar medical for investors a great option because the company certainly has encouraging results and can provide a fantastic revenue stream for investors that are interested to purchase stocks from the company.
 
Itamar medical reported on November 27, 2018, the financial results for the third quarter of 2018. The company is involved in the development, manufacture, and distribution of noninvasive diagnostic medical devices for sleep apnea focusing on the cardiology market. The company reported they were pleased with the increases of the in third-quarter revenues which reflected the enhanced recognition among cardiologists in the US of how they could benefit from the WatchPat technology which enables the diagnosis of sleep apnea from home. The president and CEO of Itamar medical, Gilad Glick expressed confidence in the WatchPat adoption trends among cardiologists in the United States along with the new sales model and favorable insurance reimbursement decisions could enable the company to maintain sustainable growth.
 
Itamar medical is a public limited company traded on the Tel Aviv Stock exchange and has been functioning since being founded in the research and development of noninvasive medical devices to diagnose respiratory disorders. The company has been focusing on leading in the integration of sleep apnea management into the cardiac Pathway with the total sleep solution it has developed in recent times.
 
Itamar medical is presently providing solutions such as WatchPat, EndoPAT, as well as total sleep solutions and has also announced definitive agreements of $11.5 million in private placement. The products provided by Itamar medical have been accepted by cardiologists as a viable solution for diagnosing the condition of sleep apnea among people in environments that are suitable rather than sending them to in lab clinics which in most cases require appointments to be taken months in advance about from spending huge sums of money for the testing. Patients suffering from this problem often deferred their decision to undergo the testing because they did not want to be subject to intrusive testing techniques which required them to have numerous wires attached to their body. In lab clinics also required approximately two weeks before they delivered the results which in turn delayed the treatment needed by patients.
 
Investors considering an investment in Itamar medical can rest assured their investments will definitely provide a return as the solutions being offered by the company are regarded as revolutionary. Data is available to show that one in five individuals in the US is suffering from the condition of sleep apnea and approximately 80% of the people are either underdiagnosed or not diagnosed at all. The reasons for the lack of diagnosis have already been mentioned above. The devices developed by Itamar medical can give patients an opportunity to undergo the testing from an environment which is not just comfortable but is also cost-effective. The devices can be used in the comfort of the patient's home and the results delivered to the cardiologist via a portal making it possible for them to devise a plan of treatment for the patient. The benefits of the devices developed by Itamar medical are numerous and are unlikely to diminish over a period of time.
 
Investors can conduct research by themselves to understand the functioning of Itamar medical before they decide whether or not they should be investing in this company. With cardiologists and patients both commenting how easy it is for them to diagnose the condition of sleep apnea and prevent cardiovascular problems with the devices developed by Itamar medical it is unlikely that investors will come across adverse comments and will only receive encouraging information. They will definitely consider Itamar medical a good option to invest money in when they observe the kind of developments this company has been making.
 

These are 10 of the World CRAZIEST Ice Cream Flavors
Created by Tal Garner
On Nov 18, 2021